| Literature DB >> 29312776 |
Yin-Yin Qin1, Cheng-Zhi Zhou1, Zheng Zhu1, Wei-Jie Guan1, Xin-Qing Lin1, Chun-Li Liu1, Yu-Ming Zhou1, Hua Wu1, Ying-Ying Gu1, De-Hua Zhang1, Ming Ou-Yang1, Nan-Shan Zhong1, Shi-Yue Li1.
Abstract
Dermatomyositis (DM) complicated with non-small cell lung cancer (NSCLC) is not rare, and could rapidly develop into severe lung cancer [performance-status score (PS) between 2 and 4]. Moreover, tumor has remarkable heterogeneity, and it is not possible to properly target treatments in cases of relapse without knowing pathological diagnosis. We retrospectively analyzed the diagnosis and treatment of a patient with DM complicated with NSCLC, which developed into severe lung cancer with heterogeneity of the tumor during chemotherapy. In this report, we addressed that in patients with severe lung cancer, both the cancer and factors associated with exacerbation should be simultaneously managed to reduce the PS score and avoid unnecessary delay. A second biopsy is important for proper management of the tumor with heterogeneity.Entities:
Keywords: Dermatomyositis (DM); clinical management; non-small cell lung cancer (NSCLC); respiratory symptoms; second biopsy; severe lung cancer
Year: 2017 PMID: 29312776 PMCID: PMC5756961 DOI: 10.21037/jtd.2017.11.107
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895